Microenvironmental control of stem cell fate in intestinal homeostasis and disease

Journal of Pathology

Volumn 237, Issue 2, 2015, Pages 135-145

  Biswas, Sujata ^a,b   Davis, Hayley ^a   Irshad, Shazia ^a   Sandberg, Tessa ^a   Worthley, Daniel ^c   Leedham, Simon ^a,b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^c UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

Chronic inflammation; Colon; Neoplasia

Indexed keywords

ANTINEOPLASTIC AGENT; BONE MORPHOGENETIC PROTEIN; FRIZZLED PROTEIN; JAGGED1; MITOCHONDRIAL DNA; NOTCH RECEPTOR; SONIC HEDGEHOG PROTEIN; STAT3 PROTEIN; WNT PROTEIN; BIOLOGICAL MARKER;

ADULT STEM CELL; CANCER STEM CELL; CD4+ T LYMPHOCYTE; CELL FATE; CELL PROLIFERATION; COLORECTAL CANCER; ENTERITIS; HUMAN; INTESTINAL STEM CELL; INTESTINE EPITHELIUM; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; SOMATIC MUTATION; STEM CELL; STEM CELL NICHE; TUMOR MICROENVIRONMENT; ANIMAL; CELL DIFFERENTIATION; CELL LINEAGE; ENTEROPATHY; GENETICS; HOMEOSTASIS; INFLAMMATORY BOWEL DISEASE; INTESTINE; INTESTINE TUMOR; METABOLISM; PATHOLOGY; PHENOTYPE;

ANIMALS; BIOMARKERS; CELL DIFFERENTIATION; CELL LINEAGE; CELL PROLIFERATION; HOMEOSTASIS; HUMANS; INFLAMMATORY BOWEL DISEASES; INTESTINAL DISEASES; INTESTINAL NEOPLASMS; INTESTINES; PHENOTYPE; SIGNAL TRANSDUCTION; STEM CELL NICHE; STEM CELLS;

EID: 84940891850     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.4563     Document Type: Review

References (61)

1. Cheng H, Leblond CP,. Origin, differentiation and renewal of the four main epithelial cell types in the mouse small intestine. I. Columnar cell. Am J Anat 1974; 141: 461-479.
2. Potten CS,. Extreme sensitivity of some intestinal crypt cells to X and gamma irradiation. Nature 1977; 269: 518-521.
3. Scoville DH, Sato T, He XC, et al., Current view: intestinal stem cells and signaling. Gastroenterology 2008; 134: 849-864.
4. Medema JP, Vermeulen L,. Microenvironmental regulation of stem cells in intestinal homeostasis and cancer. Nature 2011; 474: 318-326.
5. Ritsma L, Ellenbroek SI, Zomer A, et al., Intestinal crypt homeostasis revealed at single-stem-cell level by in vivo live imaging. Nature 2014; 507: 362-365.
6. Van der Flier LG, Sabates-Bellver J, Oving I, et al., The intestinal Wnt/TCF signature. Gastroenterology 2007; 132: 628-632.
7. Gregorieff A, Pinto D, Begthel H, et al., Expression pattern of Wnt signaling components in the adult intestine. Gastroenterology 2005; 129: 626-638.
8. Barker N, van Es JH, Kuipers J, et al., Identification of stem cells in small intestine and colon by marker gene Lgr5. Nature 2007; 449: 1003-1007.
9. Barker N, Clevers H,. Leucine-rich repeat-containing G-protein-coupled receptors as markers of adult stem cells. Gastroenterology 2010; 138: 1681-1696.
10. Barker N, Huch M, Kujala P, et al., Lgr5(+ve) stem cells drive self-renewal in the stomach and build long-lived gastric units in vitro. Cell Stem Cell 2010; 6: 25-36.
11. Jaks V, Barker N, Kasper M, et al., Lgr5 marks cycling, yet long-lived, hair follicle stem cells. Nature Genet 2008; 40: 1291-1299.
12. Sangiorgi E, Capecchi MR,. Bmi1 is expressed in vivo in intestinal stem cells. Nature Genet 2008; 40: 915-920.
13. Takeda N, Jain R, LeBoeuf MR, et al., Interconversion between intestinal stem cell populations in distinct niches. Science 2011; 334: 1420-1424.
14. Montgomery RK, Carlone DL, Richmond CA, et al., Mouse telomerase reverse transcriptase (mTert) expression marks slowly cycling intestinal stem cells. Proc Natl Acad Sci U S A 2011; 108: 179-184.
15. van der Flier LG, van Gijn ME, Hatzis P, et al., Transcription factor achaete scute-like 2 controls intestinal stem cell fate. Cell 2009; 136: 903-912.
16. Itzkovitz S, Lyubimova A, Blat IC, et al., Single-molecule transcript counting of stem-cell markers in the mouse intestine. Nature Cell Biol 2012; 14: 106-114.
17. Munoz J, Stange DE, Schepers AG, et al., The Lgr5 intestinal stem cell signature: robust expression of proposed quiescent '+4' cell markers. EMBO J 2012; 31: 3079-3091.
18. Buczacki SJ, Zecchini HI, Nicholson AM, et al., Intestinal label-retaining cells are secretory precursors expressing Lgr5. Nature 2013; 495: 65-69.
19. Powell AE, Wang Y, Li Y, et al., The pan-ErbB negative regulator Lrig1 is an intestinal stem cell marker that functions as a tumor suppressor. Cell 2012; 149: 146-158.
20. van der Flier LG, Haegebarth A, Stange DE, et al., OLFM4 is a robust marker for stem cells in human intestine and marks a subset of colorectal cancer cells. Gastroenterology 2009; 137: 15-17.
21. Koo BK, Spit M, Jordens I, et al., Tumour suppressor RNF43 is a stem-cell E3 ligase that induces endocytosis of Wnt receptors. Nature 2012; 488: 665-669.
22. Furuyama K, Kawaguchi Y, Akiyama H, et al., Continuous cell supply from a Sox9-expressing progenitor zone in adult liver, exocrine pancreas and intestine. Nature Genet 2011; 43: 34-41.
23. Worthley DL, Giraud AS, Wang TC,. Stromal fibroblasts in digestive cancer. Cancer Microenviron 2010; 3: 117-125.
24. Auclair BA, Benoit YD, Rivard N, et al., Bone morphogenetic protein signaling is essential for terminal differentiation of the intestinal secretory cell lineage. Gastroenterology 2007; 133: 887-896.
25. Hardwick JC, Van Den Brink GR, Bleuming SA, et al., Bone morphogenetic protein 2 is expressed by, and acts upon, mature epithelial cells in the colon. Gastroenterology 2004; 126: 111-121.
26. He XC, Zhang J, Tong WG, et al., BMP signaling inhibits intestinal stem cell self-renewal through suppression of Wnt-β-catenin signaling. Nature Genet 2004; 36: 1117-1121.
27. Buller NV, Rosekrans SL, Westerlund J, et al., Hedgehog signaling and maintenance of homeostasis in the intestinal epithelium. Physiology (Bethesda) 2012; 27: 148-155.
28. Fre S, Huyghe M, Mourikis P, et al., Notch signals control the fate of immature progenitor cells in the intestine. Nature 2005; 435: 964-968.
29. van Es JH, van Gijn ME, Riccio O, et al., Notch/gamma-secretase inhibition turns proliferative cells in intestinal crypts and adenomas into goblet cells. Nature 2005; 435: 959-963.
30. Noah TK, Shroyer NF,. Notch in the intestine: regulation of homeostasis and pathogenesis. Annu Rev Physiol 2013; 75: 263-288.
31. Lopez-Garcia C, Klein AM, Simons BD, et al., Intestinal stem cell replacement follows a pattern of neutral drift. Science 2010; 330: 822-825.
32. Snippert HJ, van der Flier LG, Sato T, et al., Intestinal crypt homeostasis results from neutral competition between symmetrically dividing Lgr5 stem cells. Cell 2010; 143: 134-144.
33. Baker AM, Cereser B, Melton S, et al., Quantification of crypt and stem cell evolution in the normal and neoplastic human colon. Cell Rep 2014; 8: 940-947.
34. Vermeulen L, Morrissey E, van der Heijden M, et al., Defining stem cell dynamics in models of intestinal tumor initiation. Science 2013; 342: 995-998.
35. Tian H, Biehs B, Warming S, et al., A reserve stem cell population in small intestine renders Lgr5-positive cells dispensable. Nature 2011; 478: 255-259.
36. + secretory progenitor cells revert to stem cells upon crypt damage. Nature Cell Biol 2012; 14: 1099-1104.
37. + stem cells are indispensable for radiation-induced intestinal regeneration. Cell Stem Cell 2014; 14: 149-159.
38. Westphalen CB, Asfaha S, Hayakawa Y, et al., Long-lived intestinal tuft cells serve as colon cancer-initiating cells. J Clin Invest 2014; 124: 1283-1295.
39. Miyoshi H, Ajima R, Luo CT, et al., Wnt5a potentiates TGF-beta signaling to promote colonic crypt regeneration after tissue injury. Science 2012; 338: 108-113.
40. Preston SL, Wong WM, Chan AO, et al., Bottom-up histogenesis of colorectal adenomas: origin in the monocryptal adenoma and initial expansion by crypt fission. Cancer Res 2003; 63: 3819-3825.
41. Barker N, Ridgway RA, van Es JH, et al., Crypt stem cells as the cells-of-origin of intestinal cancer. Nature 2009; 457: 608-611.
42. Schwitalla S, Fingerle AA, Cammareri P, et al., Intestinal tumorigenesis initiated by dedifferentiation and acquisition of stem-cell-like properties. Cell 2013; 152: 25-38.
43. Jaeger E, Leedham S, Lewis A, et al., Hereditary mixed polyposis syndrome is caused by a 40-kb upstream duplication that leads to increased and ectopic expression of the BMP antagonist GREM1. Nature Genet 2012; 44: 699-703.
44. Davis H, Irshad S, Bansal M, et al., Aberrant epithelial GREM1 expression initiates colonic tumorigenesis from cells outside the stem cell niche. Nature Med 2015; 21: 62-70.
45. De Sousa EMF, Wang X, Jansen M, et al., Poor-prognosis colon cancer is defined by a molecularly distinct subtype and develops from serrated precursor lesions. Nature Med 2013; 19: 614-618.
46. Sadanandam A, Lyssiotis CA, Homicsko K, et al., A colorectal cancer classification system that associates cellular phenotype and responses to therapy. Nature Med 2013; 19: 619-625.
47. Marisa L, de Reynies A, Duval A, et al., Gene expression classification of colon cancer into molecular subtypes: characterization, validation, and prognostic value. PLoS Med 2013; 10: e1001453.
48. Isella C, Terrasi A, Bellomo SE, et al., Stromal contribution to the colorectal cancer transcriptome. Nature Genet 2015; 47: 312-319.
49. Calon A, Lonardo E, Berenguer-Llergo A, et al., Stromal gene expression defines poor-prognosis subtypes in colorectal cancer. Nature Genet 2015; 47: 320-329.
50. Kirkland SC,. Clonal origin of columnar, mucous, and endocrine cell lineages in human colorectal epithelium. Cancer 1988; 61: 1359-1363.
51. Vermeulen L, Todaro M, de Sousa Mello F, et al., Single-cell cloning of colon cancer stem cells reveals a multi-lineage differentiation capacity. Proc Natl Acad Sci U S A 2008; 105: 13427-13432.
52. Dexter DL, Barbosa JA, Calabresi P,. N,N-Dimethylformamide-induced alteration of cell culture characteristics and loss of tumorigenicity in cultured human colon carcinoma cells. Cancer Res 1979; 39: 1020-1025.
53. Merlos-Suarez A, Barriga FM, Jung P, et al., The intestinal stem cell signature identifies colorectal cancer stem cells and predicts disease relapse. Cell Stem Cell 2011; 8: 511-524.
54. Zeuner A, Francescangeli F, Contavalli P, et al., Elimination of quiescent/slow-proliferating cancer stem cells by Bcl-XL inhibition in non-small cell lung cancer. Cell Death Differ 2014; 21: 1877-1888.
55. Kreso A, Dick JE,. Evolution of the cancer stem cell model. Cell Stem Cell 2014; 14: 275-291.
56. Greaves M, Maley CC,. Clonal evolution in cancer. Nature 2012; 481: 306-313.
57. Vermeulen L, De Sousa EMF, van der Heijden M, et al., Wnt activity defines colon cancer stem cells and is regulated by the microenvironment. Nature Cell Biol 2010; 12: 468-476.
58. Todaro M, Gaggianesi M, Catalano V, et al., CD44v6 is a marker of constitutive and reprogrammed cancer stem cells driving colon cancer metastasis. Cell Stem Cell 2014; 14: 342-356.
59. Kirchberger S, Royston DJ, Boulard O, et al., Innate lymphoid cells sustain colon cancer through production of interleukin-22 in a mouse model. J Exp Med 2013; 210: 917-931.
60. Lotti F, Jarrar AM, Pai RK, et al., Chemotherapy activates cancer-associated fibroblasts to maintain colorectal cancer-initiating cells by IL-17A. J Exp Med 2013; 210: 2851-2872.
61. Lu J, Ye X, Fan F, et al., Endothelial cells promote the colorectal cancer stem cell phenotype through a soluble form of Jagged-1. Cancer Cell 2013; 23: 171-185.